C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils

Blood

Volumn 100, Issue 2, 2002, Pages 517-523

  Wojta, Johann ^a,b,c   Kaun, Christoph ^a,b,c   Zorn, Gerlinde ^a,b,c   Ghannadan, Minoo ^a,b,c   Hauswirth, Alexander W ^a,b,c   Sperr, Wolfgang R ^a,b,c   Fritsch, Gerhard ^a,b,c   Printz, Dieter ^a,b,c   Binder, Bernd R ^a,b,c   Schatzl, Georg ^a,b,c   Zwirner, Joerg ^a,b,c   Maurer, Gerald ^a,b,c   Huber, Kurt ^a,b,c   Valent, Peter ^a,b,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; MESSENGER RNA; PERTUSSIS TOXIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BASOPHIL; CARDIOVASCULAR DISEASE; COMPLEMENT SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY; TISSUE REPAIR;

EID: 0037100538     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.2.517     Document Type: Article

References (39)

1. Biology of disease: New insights into "the riddle of the mast cells": Microenvironmental regulation of mast cell development and phenotypic heterogeneity
2. Basophils and mast cells: Piecemeal degranulation in situ and ex vivo: Possible mechanism for cytokine-induced function in disease
3. The mast cell
4. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell-dependent
5. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis
6. Degranulation of human mast cells induces an endothelial cell antigen central to leukocyte adhesion
7. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α
8. Mediators of immediate hypersensitivity reactions
9. Two human mast cell subsets with distinct neutral protease compositions
10. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores
11. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines
12. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis
13. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: Abundant expression of major basic protein in mast cells
14. Regulation of synthesis and secretion of plasminogen activators by endothelial cells
15. Normal endothelial cell function
16. Regulation of PAJ-1 gene expression
17. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells
18. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma
19. Transgenic mouse models in angiogenesis and cardiovascular disease
20. Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques
21. Localization of the terminal C5b-9 complement complex in the human aortic atherosclerotic wall
22. Complement activation and atherosclerosis
23. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery
24. The molecular role of mast cells in atherosclerotic cardiovascular disease
25. Immunological characterization and functional importance of human heart mast cells
26. Role of cardiac mast cells in complement C5a-induced myocardial ischemia
27. Complement activation in heart diseases: Role of oxidants
28. Bloodand skin-derived monocytes/macrophages respond to C3a but not to C3a (desArg) with a transient release of calcium via a pertussis sensitive signal transduction pathway
29. Establishment of an immature mast cell line from a patient with mast cell leukemia
30. Differential expression of complement receptors on human basophils and mast cells
31. The basophil activation marker defined by antibody 97A6 is identical to the ectonucleotide pyrophosphatase/ phosphodiesterase 3
32. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies
33. Plasma protein C inhibitor is elevated in survivors of myocardial infarction
34. Notoginsenoside R1 counteracts endotoxin-induced activation of endothelial cells in vitro and endotoxin-induced lethality in mice
35. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells
36. C3a and C5a stimulate chemotaxis of human mast cells
37. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway
38. Inactivation of human anaphylatoxin C5a and C5a des-Arg through cleavage by the plasminogen activator activity of a human fibrosarcoma cell line
39. Expression of C5a-receptor (CD88) on synovial mast cells in patients with rheumatoid arthritis